Literature DB >> 3081516

Isolation and characterization of type VIII collagen synthesized by cultured rabbit corneal endothelial cells. A conventional structure replaces the interrupted-helix model.

P D Benya, S R Padilla.   

Abstract

Radioactive proline-labeled type VIII collagen was biosynthesized in the presence of beta-aminoproprionitrile by rabbit corneal endothelial cells and isolated from the culture medium. Type VIII was purified in the presence of protease inhibitors and at neutral pH by ultrafiltration, precipitation with 3.9 M NaCl, sedimentation in sucrose gradients, and DEAE-Sephacel chromatography. The major components of this collagen, VIII-1, -2, and -3, exhibited apparent molecular weights of greater than 194,000, 124,000, and 61,000, respectively, and were shown to contain identical CNBr peptides. Following separation of VIII-1, -2, and -3 from each other and any residual proteases by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, exposure to acetic acid led to the conversion of VIII-1 to VIII-2 and VIII-3. Thus, VIII-1 is not a continuous single peptide chain, and the preliminary interrupted-helix model of the type VIII structure (Benya, P. D. (1980) Renal Physiol. 3, 30-35) was revised. VIII-3 appears to be the parent alpha 1 (VIII)-chain, with VIII-2 and VIII-1 representing beta- and gamma-chain configurations stabilized by strong noncovalent acid-labile interactions and beta-aminoproprionitrile-insensitive covalent cross-links. Based on two-dimensional CNBr peptide mapping, the alpha-chain is composed of six peptides. Mr 5,300-19,600. The terminal peptides are pepsin sensitive and correlate with two noncollagenous domains, NC1 (Mr 14,700) and NC2 (Mr 4-5,000). NC1 contains the site of acid-labile chain association.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081516

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Type VIII collagen is a product of vascular smooth-muscle cells in development and disease.

Authors:  J R MacBeath; C M Kielty; C A Shuttleworth
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

2.  Partial characterization of a low molecular weight human collagen that undergoes alternative splicing.

Authors:  T Pihlajaniemi; R Myllylä; J Seyer; M Kurkinen; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

Review 3.  Collagens in ocular tissues.

Authors:  G E Marshall; A G Konstas; W R Lee
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

4.  The spatial organization of Descemet's membrane-associated type IV collagen in the avian cornea.

Authors:  J M Fitch; D E Birk; C Linsenmayer; T F Linsenmayer
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

Review 5.  Basement membranes in the cornea and other organs that commonly develop fibrosis.

Authors:  Paramananda Saikia; Carla S Medeiros; Shanmugapriya Thangavadivel; Steven E Wilson
Journal:  Cell Tissue Res       Date:  2018-10-03       Impact factor: 5.249

6.  Microfilament modification by dihydrocytochalasin B causes retinoic acid-modulated chondrocytes to reexpress the differentiated collagen phenotype without a change in shape.

Authors:  P D Benya; P D Brown; S R Padilla
Journal:  J Cell Biol       Date:  1988-01       Impact factor: 10.539

7.  Type VIII collagen has a restricted distribution in specialized extracellular matrices.

Authors:  R Kapoor; L Y Sakai; S Funk; E Roux; P Bornstein; E H Sage
Journal:  J Cell Biol       Date:  1988-08       Impact factor: 10.539

8.  Characterization of the collagen in the hexagonal lattice of Descemet's membrane: its relation to type VIII collagen.

Authors:  H Sawada; H Konomi; K Hirosawa
Journal:  J Cell Biol       Date:  1990-01       Impact factor: 10.539

9.  Change in long-spacing collagen in Descemet's membrane of diabetic Goto-Kakizaki rats and its suppression by antidiabetic agents.

Authors:  Yoshihiro Akimoto; Hajime Sawada; Mica Ohara-Imaizumi; Shinya Nagamatsu; Hayato Kawakami
Journal:  Exp Diabetes Res       Date:  2008
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.